Thu, Jul 31, 2014, 5:42 AM EDT - U.S. Markets open in 3 hrs 48 mins

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

terry_insm 112 posts  |  Last Activity: Jul 29, 2014 10:40 AM Member since: Nov 22, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I have long known about Kevin trolling these Yahoo! message boards pushing penny bios or pink sheet Canadian pharma wannabes.
    Kevin is many IDs Posing as a investor guru, "doc' etc , it's just him, the MO is the same. After the Celtrix /Insmed penny stock debacle,
    kvcmcdd became a fixture here posting red flag risky garbage ( (example ADXS on this bd/ last year below)
    Pandering to INSM SHDRS .he has convinced a few. Friday kvncmcdd was pushing CYTR or DelMar Pharma junk. ......Kevin knows I know.
    Kevin is not a trader investor, he is however looking for suckers........Caveat emptor
    ----------------
    kvnmcdd 1/2013 INSM msg bd.= "Wow this is amazing news ADXS might have a treatment or cure for cervical cancer!
    Put this one on your watch list. This one will be $2.00 one day.Cancer cure" On many Yahoo boards including this one
    I believe 1 or 2 posters here bought it (ADXS 12 cents then, now R/S 2 cents )

  • Reply to

    Late breaking abstract: 91% reenrollment

    by jsblvbjb May 18, 2014 2:58 PM
    terry_insm terry_insm May 19, 2014 10:36 AM Flag

    The Institutional Ownershp:....77.4 % AS OF MARCH 31- This is late May and there has been selling, a lot of it since I called the reversal on April 2. Good Luck.

  • Reply to

    Trading verses science

    by kinkey_boots Apr 5, 2014 2:07 PM
    terry_insm terry_insm Jun 3, 2014 12:18 AM Flag

    ok Mike, just saw that that post was deleted ..Insmed broke a trendline today signalling another leg down...
    and normally I would trust the chart had it not been for the sneaky PR Friday..YTD+97% and some shorts to cover. Congrats on

    Mannkind.............................. Good Luck ---

    Sorry about my 19.79 sell call 4 trading days ago by terry_insm •Apr 7, 2014
    (Trendline change strong reversal signal- I posted it 4 times)
    disliked this post **18 ** (too bad you could have sold@ $20 )

    Some action today by terry_insm • May 12, 2014 4:09 PM
    disliked this post **21** (too bad you could have sold@16)
    thats a good bet ) ......15.93 then ...Look its a Golden Cross ! ....(50 x200)
    I subsequently posted the target,but wont now

  • terry_insm terry_insm Jun 16, 2014 10:15 AM Flag

    ********** The FDA will not disclose information regarding sponsors who have been granted or denied breakthrough therapy designation. FDA will respond to breakthrough therapy designation requests within 60 days of receipt of the request. ---- Insmed does not have to say a word. - clever (or hidden in a PR coming? )).Everyone is positioned. I am on the sidelines.....we shall see. Good Luck -no trading,surfs up!

  • Reply to

    Telegraphing the delay

    by terry_amln May 20, 2014 6:08 PM
    terry_insm terry_insm May 22, 2014 11:03 PM Flag

    -Uncertainty is always bad for a stocks price, but will make for good trading.The MMs will take adv as I will YTD +90% have more fun

  • terry_insm terry_insm Jun 16, 2014 8:49 AM Flag

    Breakthrough status is in fact the same as fast track but with a vague "guidance" from the FDA to speed up approval. Some observers think the FDA is actually favoring too many candidates and thereby diluting its resources through expedited review programs, thus diluting its resources so much that in fact none of them will see much difference in the approval shortening time.
    Also other agencies around the world may not accept the FDAs decision. Pharma agencies around the world are notoriously snobby.
    -On the face of it, I think Arikayce should receive the status,but if it doesn't , I really don't think its that big a deal. Traders will use it as an excuse to move it up or down.
    -IMHO - the regulatory pathway yet to be determined is more important. A mandated Phase3 trial will affect the company far more.

  • Reply to

    Bought more today

    by zake1 Jun 3, 2014 10:57 AM
    terry_insm terry_insm Jun 4, 2014 4:34 AM Flag

    Greg Wade ( phD) left Wedbush and his recc behind , but since it was a polarizing call ...... Greg went to work for Pharmacyclics .. a company I use to own. Dr Wade called for additional trialing of Arikayce and that Insmed did not /would not have the needed information from trialing the FDA demands. Now INSM is 5 bucks from his call ,but those that shorted after the results ( uhmm I blush) have done well. 19.79 to 11.87

    - "Biotech sector has reset-Piper J $51 -who would believe such a thing ? by terry_insm • Apr 25, 2014 "
    Good Luck

  • Reply to

    Down over 4%

    by ltdobanion May 19, 2014 11:36 AM
    terry_insm terry_insm May 19, 2014 11:43 AM Flag

    The manipulation was up 120%. I am so glad you put me on ignore when I told you to listen to the phase3 talk at the Insmed CC. Insmed will not be entering the US market for CF.Everything is not wonderful but I am up 83% ytd ....The setup is obvious but here in eraseerville,I am no longer posting INSM trades and this one is very obvious Good Luck GOGO INSM ...surfs up kids!

  • terry_insm terry_insm May 21, 2014 2:53 PM Flag

    Not surprised given I read the news. Sure the results on NTM were stellar ,but the changing of the timeline wording to "several months in negotiations ' MAY mean the agencies want more testing. Good Luck
    ------------------------------------
    Investor DD - change to the Investor presentation Feb 2014 Timeline by terry_insm • Feb 25, 2014

    The investor materials presented on the Insmed website reflects the **possible ** change to the NTM timeline.
    The current investor presentation dated Feb 2014. There is no doubt Insmed did this for a reason.
    Potential time to launch (page 8) was changed from mid 2015 to 2015-2017 + (plus)
    "Preparations are underway"

    My ignore for the clowns is on but for those who invest this change is current. imho - there will be "additional work to be done ". Each investor can evaluate his or her own risk tolerance. If Insmed for the first time in their history releases data worthy of a filing,Institutions will fluctuate the trading to allow for a position Good Luck

  • -This is no doubt a buying opportunity if Insmed gets some good calls from the FDA.
    I think the timeline will be longer but below is NOT what you want to do holding a biotech stock
    No investor adviser would ever invest as you did kvnmcdd You're not kidding anyone. Now get to work deleting!! Smile

    1- You sell the News and take a 25% loss- 3/26 Insmed opens @18.69
    kvnmcdd • Mar 26, 2014 "Listened to most of the call...and I pulled the sell trigger and sold ") ($ 15.60)

    2-the stock runs up close to $20 and you buy the rally at the top.
    kvnmcdd • Apr 4, 2014 10:23 AM I was all back in on Monday.. ($ 19.76)

    3- You ignore a strong sell signal - by terry_insm •Apr 2, 2014 10:07 AM
    The 19.79 sell signal was valid and the chart TODAY HAS A NEW SIGNAL. Ill send the signal to my secret admirers (chart signal started a downtrend.)

    4- The stock tumbles to the $13,6 area for another 30% and you buy a rumor from Piper Jeffery
    "I bought more today! ( $14.50 ) add 7% loss

    YTD Kevin you have lost 60% of whatever you started with this year if anyone possibly believes you and normally I would have sympathy.instead I just smile..

  • terry_insm terry_insm May 22, 2014 1:48 PM Flag

    Today is short covering in the biotech sector. The market will resume after the weekend holiday - ) 1 trade

  • Reply to

    is anyone else

    by hubby_14508 May 21, 2014 2:25 PM
    terry_insm terry_insm May 22, 2014 10:00 AM Flag

    Please Evelyn - go over and stay at invsrvillge. Those bds are useless with only pumping allowed.
    fudfighter 234..investorvillage blasdp31 b-leagured and insmview is just a few of your identities.hubby nailed it

  • Reply to

    Late breaking abstract: 91% reenrollment

    by jsblvbjb May 18, 2014 2:58 PM
    terry_insm terry_insm May 19, 2014 5:07 AM Flag

    DISINFORMATION -Last week fudkvn posted 3 pieces of disinformation:#1 - NEWS: EMA Filing for CF and NTM in 2H 2014=false #2 87% institutional holdings at March 31=false #3 New Insmed Price target now $32.83 (Wedbush removed)=false
    Insmed does not know their reg path or when if they will file or a dual file
    77.4% is the real IH number plenty of trading spread.
    Wedbush last call was to reiterate additional trials A $7target

  • Reply to

    When there's bad news the price drops ...

    by insmview May 19, 2014 2:41 PM
    terry_insm terry_insm May 19, 2014 3:15 PM Flag

    The posters and presentation highlight Arikayces high points,but it really means very little to investors and those that paint this as Huge!. The question is what is the regulatory pathway.What is going to be needed to get the drug approved .(the "poster glorifying CF means NOTHING to US sales.-unless the FDA gives a pass- so far nope. ..A NTM trial or CF or both or delay will hurt the stock. A breakthru status a clear pathway and I will be a long. When someone asks a question besides the clownsconstant drone of hype,it should be considered.

  • Reply to

    !!1st drug to show efficacy against NTM!!

    by blank2thisone May 21, 2014 3:10 AM
    terry_insm terry_insm May 21, 2014 11:10 AM Flag

    alazoner kevin etc - enjoy posting to yourself? You are such a fraud You posted you qwere all in @ 19.76 when that was thumbworthy... Traded live just for you LOL + 90% on Insmed and you know it. Have more fum

  • terry_insm terry_insm May 22, 2014 11:14 AM Flag

    My post was from February when Insmed first let investors know the NTM results would need clarity and the timeline was indeed pushed out (2015-2017 +) from the mid 2015 hope of 2013.... The new presentation of May shows as you say 2015-16 timeline+ and yesterday the PR simply said "several months" before decision on the regulatory pathway in Europe AND the US would be known. This is NOT a filing or a launch date - it is a date when the company knows what to prepare for- a new trial or filing prep. I agree the breaktrru designation should be known shortly (covering rally and then a pullback -)). As you can see many didn't understand the PR yesterday and are baffled- they shouldn't be,Insmed has been telegraphing what they know. Good Luck

  • Reply to

    Trades

    by doughcm Mar 21, 2014 6:47 PM
    terry_insm terry_insm May 29, 2014 12:01 PM Flag

    Nice work ladies! I'm back to trade!.he poster of the open option interest as a short hedge has it right - )
    The chart is an obvious and I see my trade was deleted--Have more fun ! YTD +90% and short INSM - I love this stock! ............... Will trade tomorrow Surfs Up! Good Luck

  • terry_insm terry_insm Jun 13, 2014 10:35 AM Flag

    I blush .... MMs are doing simple trading as there are little shares and everyone is positioned Good Luck
    Jun 6, 2014 05:40 AM # signal # trigger GLBuy 12:10 GL 3500k @12.27
    Jun 11,2014 10:10 AM Just SOLD all ( 6 lots - 13.41 )
    on the sidelines .... YTD +120%, I tried to tell ya..... Surfs up kids! .

  • terry_insm • Jun 27, 2014 3:10 PM.- "Short @.19.51 all you can
    ( I also added the following Monday morning @ 20.45 ( RSI @ 80) with the blow off top.
    kvncmcdd • Jun 27, 2014 "$19.51 I added 15,000 shares right at the close."
    "by kvnmcdd • Jul 7th trade of 19.98 ! Added 4,000 shares...and your 11,000 shares 30k ,wow!

    I am (excluding this trade +127% ytd INSM. A technical trader understands this trade. I only post
    the call not the strategy,because it is so much fun to watch theseclowns makeupsht in response.
    Good Luck -
    Actual posted trades before Kevin deleted them on 7/18...

  • Reply to

    Will break 19 today

    by jimmy8049 Jun 25, 2014 9:28 AM
    terry_insm terry_insm Jun 26, 2014 8:55 AM Flag

    Is Insmed telegraphing a Limited patient population Filing. ?
    We can all laugh at 100k patients x 100k = 10 billion and $500 a share! , but Lewis may have telegraphed a filing for a limited population followed by a larger trial for a larger NTMpatient population.
    How would the street react ?
    Would a dilution be necessary? . Would reality finally set in that this is an orphan indication?
    Positioning -The chart is flagging and setting a base, After posting all my Insmed trades this year,I will not post my current trade

INSM
17.51+0.01(+0.06%)Jul 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.